Form D · Other
BioNeex Inc
Syracuse, NY · CIK 0001921981
Offering snapshot reported Apr 6, 2022 · SEC filing
- Reported sold
- $65K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 23, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2022 | Initial | $65,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-440728
Source: Form D, filed Apr 6, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Smbat Rafayelyan | Director, Executive |
| Tigran Rafayelyan | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1119 N Townsend St Apt 204
Syracuse, NY, 13208
Syracuse, NY, 13208